Katharina Dendl

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors.

Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 10, 2024

Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer.

Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer.

Journal: PET clinics

Published: May 31, 2023

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease.

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease.

Journal: Radiology

Published: January 03, 2023

Three-Time-Point PET Analysis of 68Ga-FAPI-46 in a Variety of Cancers.

Three-Time-Point PET Analysis of 68Ga-FAPI-46 in a Variety of Cancers.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: September 20, 2022

Distinguishing Benign and Malignant Findings on [68 Ga]-FAPI PET/CT Based on Quantitative SUV Measurements.

Distinguishing Benign and Malignant Findings on [68 Ga]-FAPI PET/CT Based on Quantitative SUV Measurements.

Journal: Molecular imaging and biology

Published: May 23, 2022

Detecting and Locating the Site of Local Relapse Using 18F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation Therapy.

Detecting and Locating the Site of Local Relapse Using 18F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation Therapy.

Journal: Molecular imaging and biology

Published: May 11, 2022

Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies.

Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies.

Journal: Seminars in nuclear medicine

Published: March 20, 2022

Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions.

Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 25, 2022

Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer.

Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer.

Journal: Molecular imaging and biology

Published: November 10, 2021

Imaging of oligometastatic disease in selected urologic cancers

Imaging of oligometastatic disease in selected urologic cancers

Journal: Der Urologe. Ausg. A

Published: October 13, 2021

[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease.

[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 30, 2021

FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?

FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?

Journal: Cancers

Published: August 15, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026